Results

Total Results: over 10,000 records

Showing results for "cancer".
Users also searched for: colon cancer screening

441. Neds 2006V2 Maskedstats Core Weighted (pdf file)
     hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2006v2_MaskedStats_Core_Weighted.PDF
     January 01, 2019 - 965 0.00 29: Cancer of prostate 9582 0.01 30: Cancer of testis 890 0.00 31: Cancer of other male … ; other and unspecified primary 3604 0.00 42: Secondary malignancies 137580 0.11 43: Malignant neoplasm … without specification of site 4843 0.00 44: Neoplasms of unspecified nature or uncertain behavior 33568 … 0.03 45: Maintenance chemotherapy; radiotherapy 3698 0.00 46: Benign neoplasm of uterus 30192 0.03 … 47: Other and unspecified benign neoplasm 51580 0.04 48: Thyroid disorders 36347 0.03 49: Diabetes

442. Archived: Ovarian Cancer: Screening, May 2004 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/ovarian-cancer-screening-2004
     May 04, 2004 - cohort studies using transvaginal ultrasound screening reported that 59 percent to 65 percent of ovarian cancers … were diagnosed in Stage I. 10 , 11 However, there is no evidence that detecting earlier-stage tumors … earlier treatment leads to a 40 percent mortality reduction) would yield a maximum of 4 additional cancers … American Cancer Society. Cancer Facts & Figures 2003 . … Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group.

443. Evidence-based Practice Center Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-surveillance_research-protocol.pdf
     May 19, 2011 - The cancer is often localized, and most tumors have low histological grades and Gleason Scores. … half of them were expected to have early stage, low-risk tumors. 1 Thus, management of early stage … Tumor Characteristics i. Stage ii. Tumor volume iii. Gleason Score iv. PSA c. … In addition to prostate neoplasms/cancer, search terms will include “active surveillance,” “watchful … Definition of Terms TNM = Tumor stage, node involvement, and metastasis. VII.

444. Archived: Evidence Summary: Skin Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/skin-cancer-screening-july-2016
     July 26, 2016 - nonmelanoma skin cancer (NMSC) (ie, basal cell and squamous cell cancers) or melanoma skin cancer. … Although NMSC represents more than 97% of skin cancers, 1 melanoma skin cancer is the primary public … 1.01 to 2.00 mm, 4.69 (95% CI, 4.24–5.02) for tumors 2.01 to 4.00 mm, and 5.71 (95% CI, 5.10–6.39) for … tumors larger than 4.00 mm. … rather than earlier detection of invasive tumors, in the absence of changes in mortality. 30 , 31

445. Data Points 14: Use of Endocrine Therapy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/dcis-endocrine-therapy_research.pdf
     August 01, 2012 - For women with early invasive cancers, therapy was highest for women treated with BCS+RT and lowest … .1 Most breast cancers (about 75%) contain significant numbers of estrogen receptors (this is called … Use was lowest among women with ER- tumors. Use did not vary greatly across tumor size or grade. … For both groups, use was highest among women with ER+ tumors but was similar for women whose tumors … It appears that while rates of use are higher for women with early invasive cancers than for DCIS,

446. Data Points 14: Use of Endocrine Therapy (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/dcis-endocrine-therapy_research.pdf
     August 01, 2012 - For women with early invasive cancers, therapy was highest for women treated with BCS+RT and lowest … .1 Most breast cancers (about 75%) contain significant numbers of estrogen receptors (this is called … Use was lowest among women with ER- tumors. Use did not vary greatly across tumor size or grade. … For both groups, use was highest among women with ER+ tumors but was similar for women whose tumors … It appears that while rates of use are higher for women with early invasive cancers than for DCIS,

447. Chemoprevention of Breast Cancer - Recommendations and Rationale (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/MnkNvteY4Yg_8Jut4SayVN
     July 02, 2002 - recommendation The USPSTF found fair evidence that tamoxifen and raloxifene may prevent some breast cancers … average, treating such women with tamoxifen for 5 years would prevent about 3 times as many invasive cancers … women enrolled in BCPT, the women in these trials were younger, had more estrogen-receptor-negative cancers … When effective, both raloxifene and tamoxifen were effective only against estrogen receptor-positive tumors … (0.8 cancers/1,000 women taking placebo vs 3.1 cancers/1,000 women taking tamoxifen for a median of

448. Medical Therapies for Locally Advanced Gastric Adenocarcinoma (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/gastric-cancers-protocol.pdf
     January 01, 2024 - intended to inform primarily medical oncologists, alongside members of multidisciplinary teams and tumor … Recurrent cancer, metastatic cancer, early stage (T1aN0 and T1bN0), stage 4 cancer, GEJ cancer patients … stromal tumors (GIST), neuroendocrine tumors, gastric lymphoma, MALToma, other rare gastric cancers … To reduce clinical heterogeneity, we will analyze studies of patients with resectable tumors or who … * OR carcinoma* OR malignan* OR neoplas* OR tumor* OR tumour*)):ab,ti,kw) 2 'cancer palliative therapy

449. Archived: Breast and Ovarian Cancer: BRCA Genetic Testing, September 2005 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer--brca-testing-ovarian-cancer-screeni
     September 15, 2005 - for ovarian cancer. … mutations, possibly because women with BRCA1 mutations had predominantly estrogen receptor-negative tumors … Anglian Breast Cancer Study Group. Br J Cancer 2000;83:1301-8. … Australian Breast Cancer Family Study. Cancer Epidemiol Biomarkers Prev 1999;8:741-7. … Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium.

450. Localized Prostate Cancer | Effective Health Care
     effectivehealthcare.ahrq.gov/decision-aids/prostate-cancer/07.html
     June 08, 2018 - Home Consumers Clinically Localized Prostate Cancer Prostate Cancer Archived … Page 7 of 24 All Cancers Have a “Risk Group” Doctors use details about … your cancer to decide how likely it is that your cancer will grow or spread. … Your doctor will use your PSA level, Gleason Score, and tumor "T stage" to determine whether your cancer … The T stage of your cancer describes how much the cancer may have grown and how likely it is that the

451. Collaborative Modeling of U.S. Breast Cancer Screening Strategies (pdf file)
     www.uspreventiveservicestaskforce.org/Home/GetFile/1/16255/collabmodelingbc/pdf
     December 01, 2015 - of breast cancer is modeled as a continuously growing tumor. … Each tumor has a size (the fatal diameter, which differs between tumors) at which diagnosis and treatment … Variation between tumors is modeled by probability distributions of tumor growth, threshold diameter … The MISCAN-Fadia continuous tumor growth model for breast cancer. … Number of cancers diagnosed is higher in B50–74 vs.

452. Cancer-Ovarian-Contraceptives Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-ovarian-contraceptives_executive.pdf
     June 01, 2013 - compared with other common cancers. … (KQ 1, KQ 2, and KQ 3); breast, cervical, colorectal, and endometrial cancers (KQ 4 and KQ 5); and … outcomes (KQ 1, KQ 2, KQ 3), 66 to other cancers of interest (KQ 4, KQ 5), and 50 to vascular events … Increase or decrease in age-specific incidence of cancers in ever OC users versus never users Figure … (decreased risk of ovarian, colorectal, and endometrial cancers) associated with OC use can affect

453. Cancer-Ovarian-Contraceptives Executive (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cancer-ovarian-contraceptives_executive.pdf
     June 01, 2013 - compared with other common cancers. … (KQ 1, KQ 2, and KQ 3); breast, cervical, colorectal, and endometrial cancers (KQ 4 and KQ 5); and … outcomes (KQ 1, KQ 2, KQ 3), 66 to other cancers of interest (KQ 4, KQ 5), and 50 to vascular events … Increase or decrease in age-specific incidence of cancers in ever OC users versus never users Figure … (decreased risk of ovarian, colorectal, and endometrial cancers) associated with OC use can affect

454. Screening for Breast Cancer (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/Fbj5RkuC7VEsKFULEsfwUg
     January 01, 2016 - What is breast cancer? Breast cancer is cancer that occurs in the cells of the breast. … cancer. … Facts about Breast Cancer Breast cancer is one of the most common cancers in women. … more difficult to “see” on a mammogram, which makes it harder to find and accurately identify breast cancers … Click Here to Learn More About Breast Cancer and Breast Cancer Screening Breast Cancer (National

455. Layout 1 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cancer-anemia_executive.pdf
     May 01, 2006 - (deficiency of red blood cells) occurs in 13-78 percent of patients undergoing treatment for solid tumors … Tumor type, treatment regimen, and history of prior cancer therapy influence the risk and severity of … For example, among patients with solid tumors, the frequency of anemia severe enough to require red blood … cell transfusion is highest for those with lung, gynecologic, and genitourinary tumors. … Whether erythropoietic stimulants accelerate progression of some cancers, as reported by one study (n

456. Screening for Ovarian Cancer - Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/za7BqXMwT8BMz4Z_ygrvKm
     May 01, 2004 - Two large cohort studies using transvaginal ultrasound screening reported that 59% to 65% of ovarian cancers … were diagnosed in Stage I.11,12 However, there is no evidence that detecting earlier-stage tumors through … assumption that earlier treatment leads to a 40% mortality reduction) would yield a maximum of 4 additional cancers … American Cancer Society. Cancer Facts & Figures 2003. … Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group.

457. Data Points #14: Use of endocrine therapy following diagnosis of ductal carcinoma in situ or early invasive breast cancer | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/dcis-endocrine-therapy/research
     September 13, 2012 - For women with early invasive cancers, therapy was highest for women treated with BCS+RT and lowest for … Most breast cancers (about 75%) contain significant numbers of estrogen receptors (this is called estrogen … In these cases, tumor growth is stimulated by the presence of estrogen. … Both act by reducing the amount of estrogen that reaches the tumor. … It appears that while rates of use are higher for women with early invasive cancers than for DCIS, the

458. Models of Survivorship Care: Technical Brief | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/cancer-survivor-care-transition/research-protocol
     March 29, 2013 - Search "Survivors"[Mesh] OR survivorship OR survivor Filters: Humans; English 498,795 #10 Search "Neoplasms … 23257892[uid] 1 #2 Search "Survivors"[Mesh] OR survivorship OR survivor 771137 #3 Search "Neoplasms … (#1 AND #9) 0 #13 Search (#1 AND #9) Schema: all 0 #14 Search (("Survivors"[MAJR] AND "Neoplasms … late effects of treatment, second cancers, and poor quality of life, to provide a knowledge base regarding … optimal followup care and surveillance of cancers, and to optimize health after cancer treatment.

459. Data Points 16: Types of Prostate Radiation: Changes across time and geography in the use of prostate radiation technologies for newly diagnosed older cancer patients: 2006-2008 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/prostate-cancer-radiation_research.pdf
     November 01, 2012 - outcomes, especially in higher risk tumors, although evidence is lacking.5 In 2000, Medicare began … that proportion had increased to 82 percent.9 Prior examinations of the same database have shown tumor … Higher doses of CRT are associ- ated with lower tumor recurrence rates. … tumors where the indications for IMRT are not very strong (i.e., where the risk of adjacent organ … Monitoring IMRT use should be a priority for these other cancers as well as for groups of prostate

460. Statistical Brief #69: Hospitalization for Colorectal Cancer, 2006 (pdf file)
     hcup-us.ahrq.gov/reports/statbriefs/sb69.pdf
     March 01, 2009 - of cancer-related deaths.1 Unlike most cancers, colorectal cancer is considered preventable in many … in 2006, including cancers of the colon, rectum, and anus. … therapy noted as the principal diagnosis, including colorectal cancer (26.6 percent), secondary malignancies … surgical treatment used to remove malignant tumors in the colon), and one-fifth (21.8 percent) cited … colon, rectum, or anus 151,900 26.6% 2 Secondary malignancies 27,600 4.8% 3 Intestinal obstruction